(Q68091629)
Statements
Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial (English)
R I Fisher
C A Coltman
J H Doroshow
A A Rayner
M J Hawkins
J W Mier
J D McMannis
G R Weiss